Last updated on January 2019

A Study to Assess the Safety Reactogenicity and Immunogenicity of a Trivalent Inactivated Poliovirus Vaccine (IPV) Based on Sabin Strains Compared to Conventional Salk IPV in a 6 10 and 14 Weeks of Age Immunization Schedule

Brief description of study

The purpose of this study is to assess the safety and reactogenicity of 3 different dose levels of inactivated poliovirus vaccine based on Sabin strains (sIPV) in healthy participants, using conventional Salk IPV (cIPV) as an active control.

Clinical Study Identifier: NCT03566940

Contact Investigators or Research Sites near you

Start Over

Study Contact

De La Salle Health Sciences Institute- DLSUMC
Dasmarinas, Philippines

Study Contact

De La Salle University Medical Center
Dasmarinas, Philippines

Study Contact

Research Institute For Tropical Medicine
Muntinlupa, Philippines

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.